Sino Biopharmaceutical | 1177 - Net Income


Sino Biopharmaceutical reported CNY3.39B in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.01M 153K Mar/2026
Avita Medical AUD -11.62M 1.7M Dec/2025
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Jiangsu Hengrui CNY 2.18B 99.1M Jun/2026
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD 108M 38M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tectonic Therapeutic USD -25.24M 6.02M Mar/2026
Viatris USD -118.8M 295.2M Jun/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026